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The vast amount of research over the past decades has signiﬁcantly added to our knowledge of phantom limb pain. Multiple
factors including site of amputation or presence of preamputation pain have been found to have a positive correlation with
the development of phantom limb pain. The paradigms of proposed mechanisms have shifted over the past years from the
psychogenic theory to peripheral and central neural changes involving cortical reorganization. More recently, the role of mirror
neurons in the brain has been proposed in the generation of phantom pain. A wide variety of treatment approaches have been
employed, but mechanism-based speciﬁc treatment guidelines are yet to evolve. Phantom limb pain is considered a neuropathic
pain, and most treatment recommendations are based on recommendations for neuropathic pain syndromes. Mirror therapy, a
relatively recently proposed therapy for phantom limb pain, has mixed results in randomized controlled trials. Most successful
treatment outcomes include multidisciplinary measures. This paper attempts to review and summarize recent research relative to
the proposed mechanisms of and treatments for phantom limb pain.
1.Introduction
The concept of phantom limb pain (PLP) as being the pain
perceived by the region of the body no longer present was
ﬁrst described by Ambrose Pare, a sixteenth century French
military surgeon [1]. Silas Weir Mitchell, a famous Civil War
surgeon in the nineteenth century, coined the term “phan-
tom limb pain” and provided a comprehensive description
of this condition [2]. It continues to remain a poorly under-
stood and diﬃcult to treat medical condition. A recent study
estimated that there were about 1.6 million people with limb
loss in the USA in 2005 and this number was projected to
increase by more than double to 3.6 million by the year 2050
[3]. Vascular problems, trauma, cancer, and congenital limb
deﬁciency are among the common causes of limb loss. The
number of traumatic amputations has also increased since
the beginning of conﬂict in Iraq and Afghanistan [4]. The
incidence of PLP has been reported to range from 42.2 to
78.8% in patients requiring amputation [5–8].
Stump pain is described as the pain in the residual por-
tion of the amputated limb whereas phantom sensations are
the nonpainful sensations experienced in the body part that
no longer exists [6, 7]. Superadded phantom sensations are
touch and pressure-like sensations felt on the phantom limb
from objects such as clothing [9]. Risk factor for PLP are
showninTable 1.RecentstudiesreporttheprevalenceofPLP
tobemorecommonamongupperlimbamputeesthanlower
limb amputees. It was also reported to be more common
amongfemalesthanmales[10,11].Asurveyreportedgreater
overall average pain intensity and interference in females
than males and females endorsed signiﬁcantly greater catas-
trophizing, use of certain pain-coping strategies, and beliefs
relatedtoseveralaspectsofpainresultinginpooradjustment
[12]. Larger population studies are needed for more deﬁnite
establishment of the risks associated due to the site of
involvedlimborgenderofthepatientindevelopmentofPLP.
Phantom sensations and pain have been reported following
amputation of diﬀerent body parts including the eyes, teeth,
tongue, nose, breast, penis, bowel, and bladder but the most
common occurrence is following limb amputation [4]. The
phantom pain and sensation may have its onset immediately
or years after the amputation. There are reports of two peak
periods of onset, the ﬁrst within a month and the second
a year after amputation [7] .T h ep r e v a l e n c ei sr e p o r t e d2 Pain Research and Treatment
Table 1: Risk factors for phantom limb pain.
Female sex
Upper extremity amputation
Presence of preamputation pain
Residual pain in remaining limb
Time after amputation
to decrease over time after amputation [10, 11]. PLP has
been reported in people with congenital absence of limbs
[13]. Tingling, throbbing, piercing, and pins and needles
sensations were among the most commonly described types
of pain [13]. The rate of phantom pain or sensation was
not reported to be higher in people with bilateral limb
amputation than those with single limb amputation [14]. A
signiﬁcant association has been reported between the PLP
and residual limb pain [15] .T h ep r e s e n c eo fp r e a m p u t a t i o n
pain is also reported to increase the risks of developing
PLP [16]. It is likely that stress, anxiety, depression, and
other emotional triggers contribute to the persistence or
e x a c e r b a t i o no fP L P .As t u d yh a sf o u n dt h a ta m p u t e e sw i t h
depressive symptoms were more likely to characterize their
pain as more severe than those without depressive symptoms
[17].
2.Mechanisms
PLP was once thought to be primarily a psychiatric illness.
With the accumulation of evidence from research over the
pastdecades,theparadigmhasshiftedmoretowardschanges
at several levels of the neural axis, especially the cortex
[18]. Peripheral mechanisms and central neural mechanisms
are among the hypotheses that have gained consensus as
proposedmechanismsovertherecentyears.Proposedmech-
anisms to explain phantom limb pain are shown in Table 2.
However none of these theoretical constructs appears to be
able to explain the phenomenon of PLP independently and
many experts believe that multiple mechanism are likely
responsible.
2.1. Peripheral Mechanism. During amputation, peripheral
nerves are severed. This results in massive tissue and
neuronal injury causing disruption of the normal pattern
of aﬀerent nerve input to the spinal cord. This is followed
by a process called deaﬀerentation and the proximal portion
of the severed nerve sprouts to form neuromas [18]. There
is an increased accumulation of molecules enhancing the
expressionofsodiumchannelsintheseneuromasthatresults
in hype-excitability and spontaneous discharges [19]. This
abnormal peripheral activity is thought to be a potential
source of the stump pain, including phantom pain [18].
Studies reporting the reduction of phantom pain with drugs
blocking the sodium channels lend further support to this
theory [20, 21]. However, this cannot explain the mecha-
nism of PLP in patients with congenital absence of limbs
[4, 18].
Table 2: Proposed theoretical mechanisms to explain phantom
limb pain.
(1) Pheripheral mechanism
Stump and neuroma hyperactivity
(2) Central neural mechanisms
Spinal cord sensitization and changes
Cortical reorganization and cortical-motor sensory
dissociation
Body schema, neuromatrix and neurosignature hypothesis
(3) Psychogenic mechanism
2.2. Central Neural Mechanisms
2.2.1.ChangesattheLevel of SpinalCord. The axonalsprouts
at the proximal section of the amputated peripheral nerve
form connections with the neurons in the receptive ﬁeld of
the spinal cord. Some neurons in the areas of spinal cord that
are not responsible for pain transmission also sprout into
the Lamina II of the dorsal horn of the spinal cord which is
the area involved in the transmission of nociceptive aﬀerent
inputs [18, 19]. This is followed by increased neuronal
activity,expansionoftheneuronalreceptiveﬁeld,andhyper-
excitability of other regions. This process is called central
sensitization. During this process, there is also an increase in
the activity at NMDA receptors mediated by neurotransmit-
ters such as substance P, tachykinins, and neurokinins at the
dorsal horn of the spinal cord [22]. This is followed by a phe-
nomenoncalledthe“windupphenomenon”inwhichthereis
an upregulation of those receptors in the area [22]. This pro-
cess brings about a change in the ﬁring pattern of the central
nociceptiveneurons.Thetargetneuronsatthespinallevelfor
the descending inhibitory transmission from the supraspinal
centers may be lost. There also may be a reduction in the
localintersegmentalinhibitorymechanismsatthelevelofthe
spinal cord, resulting in spinal disinhibition and nociceptive
inputs reaching the supra spinal centers. This lack of aﬀerent
input and changes at the level of the spinal cord have been
proposed to result in the generation of PLP [22–24].
2.2.2. Changes at the Level of the Brain. Cortical reorga-
nization is perhaps the most cited reason for the cause
of PLP in recent years. During reorganization, the cortical
areas representing the amputated extremity are taken over by
the neighboring representational zones in both the primary
somatosensory and the motor cortex [18, 25, 26]. The pro-
cess and extent of cortical reorganization have been studied
in both animal and human models following amputation
and deaﬀerentation. Cortical reorganization partly explains
why the aﬀerent nociceptive stimulation of neurons within
the stump or surrounding area produces the sensation in the
missing limb [4, 27]. The extent of cortical reorganization
has been found to be directly related to the degree of pain
and the size of the deaﬀerentiated region. Multiple imaging
studies have correlated greater extent of somatosensory cor-
tex involvement with more intense phantom limb experience
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Another proposed mechanism of PLP is based on the
“bodyschema”conceptthatwasoriginallyproposedbyHead
andHolmesin1912. Thebody schemacanbethoughtofasa
templateoftheentirebodyinthebrainandanychangetothe
body, such as an amputation, results in the perception of a
phantom limb [31]. A further expansion of the body schema
concept is the “neuromatrix and neurosignature” hypothesis
proposed by Ronald Melzack in 1989. The neuromatrix
can be conceptualized as a network of neurons within the
brain that integrates numerous inputs from various areas
including somatosensory, limbic, visual, and thalamocortical
components. It then results in an output pattern that evokes
pain or other meaningful experiences. The term “neurosig-
nature” was proposed by Melzack to refer to the patterns
of activity generated within the brain that are continuously
being updated based upon one’s conscious awareness and
perception of the body and self. The deprivation of various
inputsfromthelimbstotheneuromatrixcausesanabnormal
neurosignature to be produced that results in the generation
of PLP [32–34].The other hypothesis relative to the mecha-
nism of PLP has been derived from the research into illusory
perceptions. It has been shown that the parietal and frontal
lobes are also involved besides the primary somatosensory
cortex in the perception of the abnormal somatosensory
phenomenon [35]. Painful sensations, such as PLP, may be
related to the incongruence of motor intention and sensory
feedback and a corresponding activation of the parietal and
frontal brain areas [36, 37].
2.3. Psychogenic Mechanism. The assumption that PLP is of
psychogenicoriginhasnotbeensupportedintherecentliter-
ature even though stress, anxiety, exhaustion, and depression
are believed to exacerbate PLP [38]. A cross-sectional study
foundthatamputationinpeoplewithpersonalitytraitschar-
acterized by passive coping styles and catastrophizing behav-
ior was found to be associated with the development of PLP
independent of anxiety and depression [39]. Most research
on the relationship between psychological symptoms and
PLP has been retrospective and cross sectional rather than
longitudinal and thus limited inferences can be derived from
these studies.
3. Treatment
An u m b e ro fd i ﬀerent therapies relying on diﬀerent prin-
ciples have been proposed for the management of PLP as
shown in Table 3. However, speciﬁc treatment guidelines are
yet to evolve and most successful measures employ multi-
disciplinary approaches in the management of pain and in
rehabilitation [40].
3.1. Pharmacological Approaches
3.1.1. PreEmptive Analgesia and Anesthesia. Preemptive use
of analgesics and anesthetics during the preoperative period
is believed to prevent the noxious stimulus from the ampu-
tated site from triggering hyperplastic changes and central
neural sensitization which may prevent the ampliﬁcation of
future impulses from the amputation site [42]. However, the
results of the studies in this area have not been deﬁnitive.
A recent study reported the decrease in PLP at six months
following amputation when optimized epidural analgesia or
intravenous patient controlled analgesia was started between
48 hours preoperatively and 48 hours postoperatively [20].
Prolonged postoperative perineural infusion of ropivacaine
0.5% was reported to prevent or reduce PLP and sensations
after lower extremity amputation [21]. Ketamine, however,
was not found to signiﬁcantly reduce acute central sensiti-
zation or the incidence and severity of postamputation pain
[43]. A randomized controlled double-blind trial comparing
epidural infusions between a group receiving ketamine and
bupivacaine and another receiving ketamine and saline fol-
lowing intrathecal or epidural anesthetic for surgery showed
no signiﬁcant diﬀerence between the two groups but much
less pain at one year was reported in both groups compared
to other comparable studies [44].
3.1.2. Acetaminophen and Nonsteroidal Anti-Inﬂammatory
Drugs (NSAIDs). A cross sectional study found that acetam-
inophen and NSAIDs were the most common medications
used in the treatment of PLP [45]. The analgesic mechanism
of acetaminophen is not clear but serotonergic and multiple
other central nervous system pathways are likely to be in-
volved [46]. NSAIDs inhibit the enzymes needed for the
synthesis of prostaglandin and decrease the nociception pe-
ripherally and centrally [47].
3.1.3. Opioids. Opioids bind to the peripheral and central
opioid receptors and provide analgesia without the loss of
touch, proprioception, or consciousness. They may also di-
minish cortical reorganization and disrupt one of the pro-
posed mechanisms of PLP [4]. Randomized controlled trials
have demonstrated the eﬀectiveness of opioids (oxycodone,
methadone, morphine, and levorphanol) for the treatment
of neuropathic pain including PLP. Comparative trials have
also shown beneﬁt with opioids when compared with tri-
cyclic antidepressants and gabapentin though the opioids
were associated with more frequent side eﬀects [48]. The
total amount of opioid required to achieve analgesia may
be less when used together with other agents, such as tri-
cyclicantidepressantsoranticonvulsants,whichalsohaveuse
in neuropathic pain modulation. Tramadol, a weak opioid
and a mixed serotonin-noradrenalin reuptake inhibitor, has
also been used in the treatment of PLP [4, 49].
3.1.4. Antidepressants. Tricyclic antidepressants are among
the most commonly used medications for various neuro-
pathic pains including PLP. The analgesic action of tricyclic
antidepressant is attributed mainly to the inhibition of sero-
tonin-norepinephrine uptake blockade, NMDA receptor an-
tagonism,andsodiumchannelblockade[50].Ther oleoftri-
cyclicantidepressantsiswellestablishedinotherneuropathic
painconditions,buttheresultsaremixedrelativetotheirrole
on PLP [51]. A recent study reported excellent and stable
PLP control with an average dose of 55mg of amitryptline,
but there are others in which tricyclic antidepressants failed4 Pain Research and Treatment
Table 3: Treatments for phantom limb pain.
Pharmacotherapy Surgical/invasive procedures Adjuvant therapy
Opioids Stump revision Transcutaneous nerve stimulation
Morphine Nerve block Mirror therapy
Tramadol Neurectomy Biofeedback
Tricyclic Antidepressants Rhizotomy Temperature biofeedback
Amitriptyline Cordotomy Electro myographic biofeedback
Nortriptyline Lobectomy Massage
Imipramine Sympathectomy Ultrasound
Desipramine CNS stimulation Physiotherapy
AntiConvulsants Spinal cord stimulation Sensory discrimination training
Carbamazepine Deep brain/thalamus stimulation Prosthesis training
Oxcarbazepine Cortical stimulation Cognitive behavioral pain management
Gabapentin Electroconvulsive therapy
Pregabalin
Sodium channel blockers
Lidocaine
Bupivacaine
Mexiletine
NMDA receptor antagonist
Memantine
Ketamine
Adapted from [4, 41].
to eﬀectively control the pain. [49, 52]. Nortriptyline and
desipramine have been found to be equally eﬀective and
with less side eﬀects compared to amitriptyline [53]. A small
case series demonstrated the eﬀectiveness of mirtazapine,
an alpha 2 receptor antagonist with fewer side eﬀects than
tricyclic antidepressants in the treatment of PLP [54]. There
arecasereportsrelativetotheeﬃcacyofduloxetine,aNEand
serotonin receptor inhibitor, in the treatment of PLP [55].
Even though there may be a role for the use of SSRI and
SNRI in the treatment of neuropathic pain, the evidence is
very limited and further research is needed [56].
3.1.5. Anticonvulsants. Gabapentin has shown mixed results
in the control of PLP with some studies showing positive
results while others not showing eﬃcacy [57–59]. Carba-
mazepine has been reported to reduce the brief stabbing
andlancinatingpainassociatedwithPLP.Oxcarbazepineand
pregabalin may also play a role in the treatment of PLP, but
further studies are required [4, 60].
3.1.6. Calcitonin. The mechanism of action of calcitonin in
treatment of PLP is not clear. Studies relative to its therapeu-
tic role have been mixed [61, 62].
3.1.7. NMDA Receptor Antagonist. The mechanism of action
of NMDA receptor antagonism in PLP is not clear. Meman-
tine has shown some beneﬁts in some case studies but con-
trolled trials have shown mixed results [63, 64]. A review
concluded that memantine may be useful soon after ampu-
tation rather than for use in chronic neuropathic pain condi-
tions [65].
3.1.8. Other Medications. The beta blocker propranolol and
the calcium channel blocker nifedipine have been used for
the treatment of PLP [60]. However, their eﬀectiveness is
unclearandfurtherstudiesareneeded.Flupirtine,anNMDA
antagonistandpotassiumchannelagonist,hasbeenreported
to be eﬀective when used together with opioids in cancer-
related neuropathic pain but needs further studies for other
etiologies [66].
3.2. Nonpharmacological Treatment
3.2.1. Transcutaneous Electrical Nerve Stimulation (TENS).
Transcutaneous electrical nerve stimulation has been found
to be helpful in PLP [40]. Historically, there have been
multiple studies showing the eﬀectiveness of TENS of the
contralateral limb versus ipsilateral to decrease PLP [67].
Thoughthereisnostrongevidence,low-frequencyandhigh-
intensity TENS is thought to be more eﬀective than other
doses [68]. TENS devices are portable, are easy to use, and
have few side eﬀects or contraindications.
3.2.2. Mirror Therapy. Mirror therapy was ﬁrst reported by
Ramachandran and Rogers-Ramachandran in 1996 and is
suggested to help PLP by resolving the visual-proprioceptivePain Research and Treatment 5
dissociation in the brain [69, 70]. The patient watches the
reﬂection of their intact limb moving in a mirror placed
parasagittally between their arms or legs while simultane-
ously moving the phantom hand or foot in a manner similar
to what they are observing so that the virtual limb replaces
the phantom limb. Simian studies have shown the existence
of mirror neurons in the brain which ﬁre both at times when
an animal performs an action or observes an action [71].
Similar homologous neurons have also been discovered in
humans [72]. The presence of mirror neurons in the brain is
also supported by the phenomenon of tactile sensation in the
phantom limb elicited by touching the virtual image of the
limb in the mirror [73]. When a person with an intact limb
observes a person with amputation, he can only “empathize
about the amputation” rather than “feel it himself” because
of the null input to the mirror neurons from his intact limb.
H o w e v e r ,ap e r s o nw i t ha na m p u t a t i o nd o e sn o tr e c e i v e
such null input as the limb is amputated and this results in
the activation of mirror neurons which create a perception
of tactile sensation. Consequently, since the activation of
these mirror neurons modulates somatosensory inputs, their
activation may block protopathic pain perception in the
p h a n t o ml i m b[ 72, 73]. A randomized controlled trial of
mirror therapy in patients with lower leg amputation has
shown signiﬁcant beneﬁt of PLP versus the control group
[74]. Another controlled trial, however, reported that the
mirror condition only elicited a signiﬁcantly greater number
of phantom limb movements than the control condition but
did not attenuate phantom limb pain and sensations any
more than the control condition [75].
3.2.3. Biofeedback, Integrative, and Behavioral Methods. Al-
though there are earlier reports suggesting temperature bio-
feedback to be helpful for burning sensation of PLP, there is
no speciﬁc evidence to match speciﬁc types of PLP with spe-
ciﬁc biofeedback techniques [76] .T h e r ei sa l s oac a s er e p o r t
of visual feedback helpful in reduction of phantom pain
[74]. Guided imagery, relaxation techniques, and hypnosis
havebeenemployedinthetreatmentofdiﬀerentneuropathic
pains and may also be useful for PLP [28, 77, 78]. There are
case reports of the beneﬁcial eﬀect of acupuncture for PLP
[79, 80]. The eﬀectiveness of cognitive behavioral therapy in
n e u r o p a t h i cp a i ns y n d r o m e sh a sb e e nr e p o r t e di nan u m b e r
of case studies [81, 82].
3.2.4. Surgical Intervention. Surgical interventions are usu-
ally employed when other treatment methods have failed. A
case report relates the eﬀectiveness of lesioning the dorsal
root entry zone (DREZ) on upper limb phantom pain result-
ing from brachial plexus avulsions [83]. Another case report
showedthat,forselectedpatients,whohavenotobtainedad-
equate relief with medical management, spinal cord stim-
ulation was found to be eﬀective [84]. Case reports of
improvement of PLP with deep brain stimulation of the
periventricular gray matter and thalamic nuclei have been
published [85]. Motor cortex stimulation was also found to
be helpful in a case of PLP [86].
3.2.5. Electroconvulsive Therapy. Ac a s er e p o r to fp o s i t i v e
outcome has been published even though the mechanism
and role of ECT relative to PLP is not well understood [87].
4. Conclusion
PLP is a relatively common and disabling entity. We have
learned much about the pathophysiology and management
of PLP since it was ﬁrst described about ﬁve centuries ago.
However, there is still no one unifying theory relative to
themechanismofPLP.Speciﬁcmechanism-basedtreatments
are still evolving, and most treatments are based on rec-
ommendations for neuropathic pain. The evolution of the
mechanistic hypothesis from body schema and neuropathic
theories to the recently proposed role of mirror neurons in
the mechanism of pain have added to our understanding of
PLP. Further research is needed to elucidate the relationship
between the diﬀerent proposed mechanisms underlying PLP.
AsynthesizedhypothesisexplainingthephenomenonofPLP
is necessary in the future for the evolution of more speciﬁc
mechanism-based treatment recommendations.
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